Office of the Vice Provost for ResearchEncouraging, cultivating, and coordinating high-impact academic research across Harvard’s schools and affiliated institutions
Updated Guidance on Russia-Related Sanctions
In response to Russia’s invasion of Ukraine, the U.S. government imposed severe financial sanctions and export restrictions on Russia and individuals and entities supporting the Russian government in Russia, Belarus, and certain separatist regions of Ukraine. These restrictions are likely to change and may affect current or future University collaborations, agreements, and research projects. OVPR is closely monitoring the situation and its potential impacts on University research. Contact OVPR for assistance in determining impacts to your research, collaborations, shipments, payments, travel, and other Harvard-related activities.
Featured Strategic Initiative: Landmark Bio, PBLLC
Spearheaded by the OVPR, Landmark Bio, PBLLC is a public benefit limited liability company that was formed to advance the development of transformative new medicines by translating today’s cutting-edge research into tomorrow’s breakthrough therapies. With construction starting on the new 40,000 square-foot biomanufacturing facility at The Arsenal on the Charles in Watertown, MA, Landmark Bio plans to begin opening at the start of 2022. The initial focus of the facility will include cell and gene therapy, gene editing, and mRNA products, which offer the potential to treat or even cure diseases such as cancer, diabetes, Parkinson’s, and Alzheimer’s, among others.